↑"Symptoms and Diagnosis". Attention-Deficit / Hyperactivity Disorder (ADHD). Division of Human Development, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. 29 September 2014. Retrieved 3 November 2014.
↑ ୫.୦୫.୧Dulcan, MK; Lake, MB (2011). Concise Guide to Child and Adolescent Psychiatry (4th illustrated ed.). American Psychiatric Publishing. p. 34. ISBN9781585624164.
↑Walitza, S; Drechsler, R; Ball, J (August 2012). "Das schulkind mit ADHS" [The school child with ADHD]. Ther Umsch (in ଜର୍ମାନ). 69 (8): 467–73. doi:10.1024/0040-5930/a000316. PMID22851461.
↑Global Burden of Disease Study 2013, Collaborators (5 June 2015). "Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013". Lancet (London, England). doi:10.1016/S0140-6736(15)60692-4. PMID26063472. {{cite journal}}: |first1= has generic name (help)CS1 maint: numeric names: authors list (link)
↑American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington: American Psychiatric Publishing. pp. 59–65. ISBN0890425558.
↑Faraone, SV (2011). "Ch. 25: Epidemiology of Attention Deficit Hyperactivity Disorder". In Tsuang, MT; Tohen, M; Jones, P (eds.). Textbook of Psychiatric Epidemiology (3rd ed.). John Wiley & Sons. p. 450. ISBN9780470977408.
↑Emond, V; Joyal, C; Poissant, H (April 2009). "Neuroanatomie structurelle et fonctionnelle du trouble déficitaire d'attention avec ou sans hyperactivité (TDAH)" [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)]. Encephale (in ଫରାସୀ). 35 (2): 107–14. doi:10.1016/j.encep.2008.01.005. PMID19393378.
↑ ୧୮.୦୧୮.୧୧୮.୨National Collaborating Centre for Mental Health (2009). Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults. British Psychological Society. pp. 19–27, 38, 130, 133, 317. ISBN9781854334718.
↑Huang, YS; Tsai, MH (July 2011). "Long-term outcomes with medications for attention-deficit hyperactivity disorder: Current status of knowledge". CNS Drugs. 25 (7): 539–554. doi:10.2165/11589380-000000000-00000. PMID21699268.
↑"The long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trials". Psychol. Res. Behav. Manag. 6: 87–99. September 2013. doi:10.2147/PRBM.S49114. PMC3785407. PMID24082796. Results suggest there is moderate-to-high-level evidence that combined pharmacological and behavioral interventions, and pharmacological interventions alone can be effective in managing the core ADHD symptoms and academic performance at 14 months. However, the effect size may decrease beyond this period. ... Only one paper53 examining outcomes beyond 36 months met the review criteria. ... There is high level evidence suggesting that pharmacological treatment can have a major beneficial effect on the core symptoms of ADHD (hyperactivity, inattention, and impulsivity) in approximately 80% of cases compared with placebo controls, in the short term.22{{cite journal}}: Cite uses deprecated parameter |authors= (help)CS1 maint: unflagged free DOI (link)